MNKD·56400P706·US·equity·Healthcare - Biotechnology-13D/G
MNKD (MANNKIND CORP) is held by 133 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($70.1M), STATE STREET CORP ($45.8M), UBS Group AG ($20.2M). Net institutional sentiment: Mixed.
See how MNKD's score breaks down across 4 SEC sources
Showing 1-20 of 153
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer